Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction

An evaluation of the trimmed mean approach in clinical trials with dropout

(2018) Ming-Dauh Wang et al.   PHARMACEUTICAL STATISTICS

Missing data in clinical trials: control-based mean imputation and sensitivity analysis

(2017) Devan V. Mehrotra et al.   PHARMACEUTICAL STATISTICS

Modeling continuous response variables using ordinal regression

(2017) Qi Liu et al.   STATISTICS IN MEDICINE

Trimmed means for symptom trials with dropouts

(2016) Thomas Permutt et al.   PHARMACEUTICAL STATISTICS

Comments on ‘Estimands in clinical trials - broadening the perspective’

(2016) Thomas Permutt   STATISTICS IN MEDICINE

Comments on ‘Estimands in clinical trials - broadening the perspective’

(2016) Peter Bauer   STATISTICS IN MEDICINE

Estimands in clinical trials - broadening the perspective

(2016) Mouna Akacha et al.   STATISTICS IN MEDICINE

Choice of estimand and analysis methods in diabetes trials with rescue medication

(2015) Björn Holzhauer et al.   PHARMACEUTICAL STATISTICS

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

(2014) Elisabeth H. Bel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Missing data sensitivity analysis for recurrent event data using controlled imputation

(2014) Oliver N. Keene et al.   PHARMACEUTICAL STATISTICS

Converting an odds ratio to a range of plausible relative risks for better communication of research findings

(2014) R. L. Grant   BMJ-British Medical Journal

Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation

(2013) James R. Carpenter et al.   Journal of Biopharmaceutical Statistics

Intent-to-treat analysis in the presence of off-treatment or missing data

(2010) Oliver N. Keene   PHARMACEUTICAL STATISTICS